Abstract

The accuracy of reported sample results is contingent upon the quality of the assay calibration curve, and as such, calibration curves are critical components of ligand binding and other quantitative methods. Regulatory guidance and lead publications have defined many of the requirements for calibration curves which encompass design, acceptance criteria, and selection of a regression model. However, other important aspects such as preparation and editing guidelines have not been addressed by health authorities. The goal of this publication is to answer many of the commonly asked questions and to present a consensus and the shared views of members of the ligand binding assay (LBA) community on topics related to calibration curves with focus on providing recommendations for the preparation and editing of calibration curves.

Highlights

  • Calibration curves illustrate the relationship between the detected response variable and the concentration of a reference standard that is presumed to be representative of the analyte of interest in a test sample

  • Calibration curves are prepared by spiking the target analyte into a matrix that has been judged to be representative of the test sample matrix

  • The content of this publication may be applicable to subsets of biomarker assays, its focus remains on calibration curves for quantitative pharmacokinetic (PK) ligand binding assay (LBA)

Read more

Summary

INTRODUCTION

Calibration curves illustrate the relationship between the detected response variable and the concentration of a reference standard that is presumed to be representative of the analyte of interest in a test sample. The general requirements for the design of calibration curves, the acceptance criteria for individual calibrators, and the guidelines for the selection of an appropriate regression model have been defined in regulatory guidance documents and lead publications by subject matter experts [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17].

22 Page 2 of 16
Required
22 Page 4 of 16
22 Page 6 of 16
22 Page 8 of 16
22 Page 12 of 16
Findings
22 Page 14 of 16
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.